Literature DB >> 19264468

Inverse temporal changes of lipoxin A4 and leukotrienes in children with Henoch-Schönlein purpura.

Sheng-Hua Wu1, Pei-Yuan Liao, Pei-Ling Yin, Yong-Mei Zhang, Ling Dong.   

Abstract

The pathogenesis of Henoch-Schönlein purpura (HSP) is not clearly understood. It remains unclear how changes of lipoxin A(4) (LXA(4)) that acts as a "braking signal" in inflammatory process occur in patients with HSP. In this study, we determined the temporal changes of blood and urinary LXA(4), Leukotriene (LT)B(4) and urinary LTE(4) in 49 children with HSP. Inverse temporal changes between gradually increased blood and urinary LXA(4) and gradually decreased blood and urinary LTB(4) and urinary LTE(4) were found in patients with HSP. Furthermore, both 15-S-hydroxyeicosatetraenoic acid and LXA(4) inhibited the LTB(4)-induced chemotaxis of leukocytes and release of LTB(4) from leukocytes obtained from the patients in the active phase of HSP. In 22 children with HSP nephritis, concordant with the gradually increased severity of mesangial proliferation and proteinuria, the glomerular expressions of 15-lipoxygenase and the levels of urinary LXA(4) gradually decreased and the glomerular expressions of LTC(4) synthase and the urinary LTE(4) and LTB(4) gradually increased. The levels of blood and urinary LXA(4) in patients with HSP nephritis were lower than those in patients with purpura alone in early resolution of HSP. The levels of blood and urinary LTB(4) and urinary LTE(4) in the patients with HSP nephritis were higher than those in patients with purpura alone in early resolution of HSP. There was positive correlation between blood LTB(4) and serum C-reactive protein in 49 children with HSP. These data suggest that LTs may play a proinflammatory and profibrotic role in the pathogenesis of HSP, and insufficiency of LXA(4) may be responsible for the patients with HSP whose illness become more serious.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264468     DOI: 10.1016/j.plefa.2009.01.008

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  11 in total

Review 1.  Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?

Authors:  Charles N Serhan
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

2.  Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients.

Authors:  Padmini S Pillai; Stanley Leeson; Timothy F Porter; Christopher D Owens; Ji Min Kim; Michael S Conte; Charles N Serhan; Simon Gelman
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

3.  Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation.

Authors:  Sungwhan F Oh; Padmini S Pillai; Antonio Recchiuti; Rong Yang; Charles N Serhan
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

4.  Resolvin E1 regulates adenosine diphosphate activation of human platelets.

Authors:  Gabrielle Fredman; Thomas E Van Dyke; Charles N Serhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-11       Impact factor: 8.311

5.  Elevated serum heme oxygenase-1 and insulin-like growth factor-1 levels in patients with Henoch-Schonlein purpura.

Authors:  Tao Chen; Zai-Pei Guo; Yu-Hong Zhang; Ying Gao; Hong-Jie Liu; Jing-Yi Li
Journal:  Rheumatol Int       Date:  2009-12-16       Impact factor: 2.631

6.  Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways.

Authors:  Thea Morris; Melanie Stables; Paul Colville-Nash; Justine Newson; Geoffrey Bellingan; Patricia M de Souza; Derek W Gilroy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

7.  Lipoxins as biomarkers of lupus and other inflammatory conditions.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2011-05-15       Impact factor: 3.876

Review 8.  Lipid mediators in immune dysfunction after severe inflammation.

Authors:  James N Fullerton; Alastair J O'Brien; Derek W Gilroy
Journal:  Trends Immunol       Date:  2013-11-21       Impact factor: 16.687

9.  Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2016-01-13       Impact factor: 3.876

10.  Blistering eruptions with tissue eosinophilia in a child with IgA vasculitis.

Authors:  Toru Watanabe; Shinya Tsukano
Journal:  Clin Case Rep       Date:  2018-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.